Pillstats
Rx only · Powder, For Suspension · Oral

Cholestyramine

Brands: Prevalite · Questran · Cholestyramine

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers13 labelers
Packages46
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.145$0.291$0.436$0.582Nov 2025Mar 2026Jul 2026
$0.425
Latest avg · Jul 22, 2026
+192%
Since Nov 19, 2025
11
Active US suppliers
28%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

12K23K35K47K2025 Q12025 Q22025 Q32025 Q42026 Q1
36K
Rx · 2026 Q1
7.7M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Par Health USA, LLCunknown6SUPPLYING
Macleods Pharmaceuticals Limitedunknown5SUPPLYING
Bryant Ranch Prepackrepackager4SUPPLYING
Zydus Lifesciences Limitedunknown4SUPPLYING
Epic Pharma, LLCunknown4SUPPLYING
Precision Dose, Inc.unknown4SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown4SUPPLYING
PuraCap Laboratories LLC dba Blu Pharmaceuticalsunknown3SUPPLYING
Endo USA, Inc.unknown3SUPPLYING
Ajanta Pharma USA Inc.unknown2SUPPLYING
Micro Labs Limitedunknown1SUPPLYING
Upsher-Smith Laboratories, LLCunknown3EXITED 2027
TAGI Pharma, Inc.unknown3EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.